CORCEPT THERAPEUTICS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

CORT

organization

SIC: 2834

SEC Insider

$659.3M

2,627 transactions

Summary

CORCEPT THERAPEUTICS INC (CORT) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $134.8MSales: $287.2M56 insiders

Date	Insider	Type	Value
2026-06-17	MAHONEY DAVID L	Sell	$1.7M
2026-06-15	Mokari Atabak(Chief Financial Officer)	Sell	$1.6M
2026-06-02	Guyer William(Chief Development Officer)	Sell	$1.4M
2026-06-15	Mokari Atabak(Chief Financial Officer)	Sell	$897K
2026-06-01	BELANOFF JOSEPH K(Chief Executive Officer)	Sell	$895K
2026-06-15	Mokari Atabak(Chief Financial Officer)	M	$770K
2026-06-15	Mokari Atabak(Chief Financial Officer)	Sell	$755K
2026-06-16	WILSON JAMES N	Sell	$487K
2026-06-02	Guyer William(Chief Development Officer)	M	$433K
2026-06-16	WILSON JAMES N	Sell	$345K
2026-06-01	Robb Gary Charles(Chief Business Officer)	A	$55K
2026-06-02	Maduck Sean(See Remarks)	F	$32K
2026-06-02	Mokari Atabak(Chief Financial Officer)	F	$28K
2026-06-02	Robb Gary Charles(Chief Business Officer)	F	$25K
2026-06-02	Lyon Joseph Douglas(See Remarks)	F	$19K
2026-06-15	Mokari Atabak(Chief Financial Officer)	Sell	$164.9
2026-06-15	Mokari Atabak(Chief Financial Officer)	M	$0
2026-06-02	Guyer William(Chief Development Officer)	M	$0
2026-06-01	Robb Gary Charles(Chief Business Officer)	A	$0
2026-06-01	Mokari Atabak(Chief Financial Officer)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

CORCEPT THERAPEUTICS INC — Contributions, Lobbying & Contracts | Poliscope